Article
Conflicts over calcium and the treatment of COVID-19
11 Nov 2020
Abstract excerpt
Several recent studies have provided evidence that use of calcium channel blockers (CCBs), especially amlodipine and nifedipine, can reduce mortality from coronavirus disease 2019 (COVID-19). Moreover, hypocalcemia (a reduced level of serum ionized calcium) has been shown to be strongly positively associated with COVID-19 severity. Both effectiveness of CCBs as antiviral therapy, and positive associations of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
